一个新兴的MSC-外体细胞输送策略:可注射的温度敏感水凝封装外体细胞以提高治疗效果
Bei Wang1, Yiqian Ren2, Xianghua Xiao2
1The College of Life Sciences, Northwest University, Xi'an Shaanxi 710069, China.
Drug discovery today
|December 19, 2025
概括
介酶干细胞衍生的外体细胞 (MSC-EXOs) 在组织修复方面表现有前途. 将MSC-EXOs封装在可注射的热敏水凝中,可以改善它们在受伤部位的传递和治疗效果.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术纳米技术
背景情况:
- 介酶干细胞衍生外体 (MSC-EXOs) 是用于组织修复的强效纳米纤维.
- 挑战包括目标效率和MSC-EXO快速清关.
- 水凝为局部治疗提供了一个生物相容的支架.
研究的目的:
- 审查用于封装和提供MSC-EXO的热敏水凝的应用.
- 突出水凝封装的好处,以提高治疗效果.
- 讨论临床翻译的未来方向.
主要方法:
- 讨论MSC-EXO生物和特征.
- 热敏水凝设计的概述,包括凝机制和制造.
- 对 EXO 装载的水凝系统进行分析,以控制释放和特定地点的交付.
主要成果:
- 可注射的热敏水凝可以为持续的MSC-EXO释放创建局部储.
- 水凝封装改善了MSC-EXO的保留和治疗结果.
- 控制释放机制提高了特定地点的剂量和疗效.
结论:
- 热敏水凝对于局部,持续的MSC-EXO的输送是有效的.
- 优化的水凝特性和EXO净化对于临床翻译至关重要.
- 需要进一步的研究来评估长期的安全性和有效性.
相关概念视频
Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


